FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

10968611000001106: CoAprovel 300mg/25mg tablets (sanofi-aventis) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
37397801000001111 CoAprovel 300mg/25mg tablets (sanofi-aventis) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
65949601000001110 CoAprovel 300mg/25mg tablets (Sanofi) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
CoAprovel 300mg/25mg tablets (sanofi-aventis) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
CoAprovel 300mg/25mg tablets (sanofi-aventis) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
CoAprovel 300mg/25mg tablets (sanofi-aventis) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
CoAprovel 300mg/25mg tablets (sanofi-aventis) Is a Irbesartan 300mg / Hydrochlorothiazide 25mg tablets true Inferred relationship Existential restriction modifier
CoAprovel 300mg/25mg tablets (sanofi-aventis) Has active ingredient Irbesartan true Inferred relationship Existential restriction modifier
CoAprovel 300mg/25mg tablets (sanofi-aventis) Has active ingredient Hydrochlorothiazide true Inferred relationship Existential restriction modifier
CoAprovel 300mg/25mg tablets (sanofi-aventis) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
CoAprovel 300mg/25mg tablets (sanofi-aventis) Has excipient Lactose false Inferred relationship Existential restriction modifier
CoAprovel 300mg/25mg tablets (sanofi-aventis) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
CoAprovel 300mg/25mg tablets (sanofi-aventis) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
CoAprovel 300mg/25mg tablets (sanofi-aventis) Is a CoAprovel true Inferred relationship Existential restriction modifier
CoAprovel 300mg/25mg tablets (sanofi-aventis) Has specific active ingredient Hydrochlorothiazide true Inferred relationship Existential restriction modifier
CoAprovel 300mg/25mg tablets (sanofi-aventis) Has specific active ingredient Irbesartan true Inferred relationship Existential restriction modifier
CoAprovel 300mg/25mg tablets (sanofi-aventis) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
CoAprovel 300mg/25mg tablets (sanofi-aventis) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
CoAprovel 300mg/25mg tablets (sanofi-aventis) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
CoAprovel 300mg/25mg tablets (sanofi-aventis) 28 tablet 2 x 14 tablets Is pack of False CoAprovel 300mg/25mg tablets (sanofi-aventis) Inferred relationship Existential restriction modifier
CoAprovel 300mg/25mg tablets (sanofi-aventis) 28 tablet 2 x 14 tablets Has AMP True CoAprovel 300mg/25mg tablets (sanofi-aventis) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start